INOVIO PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2013 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 28.1M shares, a 25.7% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 22.2M shares, a 11.5% increase from 2022.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 19.9M shares, a 14.3% increase from 2021.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 17.4M shares, a 88.8% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 28.1M +5.76M +25.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 27.2M +5.17M +23.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 23.3M +1.76M +8.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 22.2M +2.29M +11.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 22.4M -227M -91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 22M -213M -90.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 21.5M -197M -90.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 19.9M +2.48M +14.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 249M +39M +18.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 235M +25.7M +12.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 219M +16.5M +8.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 17.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 210M +35.9M +20.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 210M +53.8M +34.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 202M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 174M +71.6M +69.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 156M +57.7M +58.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2019 103M +10.4M +11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 98.1M +6.84M +7.5% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q4 2018 92.5M +10.6M +13% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 92.4M +5.33M +6.12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 91.2M +15.8M +21% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 90.5M +16.2M +21.7% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q4 2017 81.9M +8.7M +11.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 87.1M +13.3M +18% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 75.4M +2.45M +3.36% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 74.3M +2.07M +2.87% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 73.2M +1.02M +1.41% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 73.8M -172K -0.23% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 73M +5.12M +7.55% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q1 2016 72.2M +11.3M +18.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 72.2M +11.4M +18.7% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-14
Q3 2015 74M +13.4M +22% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 67.8M +7.36M +12.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 60.9M +5.75M +10.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 60.8M +8.68M +16.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 60.6M +12.6M +26.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 60.5M +15.5M +34.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 55.2M +16.1M +41.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 52.1M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 48M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 45M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 39M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.